These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2567862)

  • 21. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
    Halmy L; Nyakas C; Walter J
    Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol enhances immunosuppression induced by cocaine.
    Pirozhkov SV; Watson RR; Chen GJ
    Alcohol Alcohol Suppl; 1993; 2():75-82. PubMed ID: 7748351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of mazindol for abuse liability.
    Pickworth WB; Klein SA; Bunker EB; Henningfield JE
    NIDA Res Monogr; 1990; 105():443. PubMed ID: 1876067
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term blockade of the dopamine uptake complex by metaphit, an isothiocyanate derivative of phencyclidine.
    Zimányi I; Jacobson AE; Rice KC; Lajtha A; Reith ME
    Synapse; 1989; 3(3):239-45. PubMed ID: 2718099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
    Bruera E; Carraro S; Roca E; Barugel M; Chacon R
    Cancer Treat Rep; 1986 Feb; 70(2):295-8. PubMed ID: 3512080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
    Coakley JH; Moorcraft J; Hipkin LJ; Smith CS; Griffiths RD; Edwards RH
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1551-7. PubMed ID: 3221222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects of mazindol on narcolepsy.
    Iijima S; Sugita Y; Teshima Y; Hishikawa Y
    Sleep; 1986; 9(1 Pt 2):265-8. PubMed ID: 3704452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mazindol, a non-phenylethylamine anorexigenic agent, on biogenic amine levels and turnover rate.
    Carruba MO; Groppetti A; Mantegazza P; Vicentini L; Zambotti F
    Br J Pharmacol; 1976 Apr; 56(4):431-6. PubMed ID: 1260223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 31. Covalent labeling of the cocaine-sensitive catecholamine transporter.
    Howard BD; Cho AK; Zhang MB; Koide M; Lin S
    J Neurosci Res; 1990 Jun; 26(2):149-58. PubMed ID: 2142222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extra-anorectic actions of mazindol.
    Jonderko K; Kucio C
    Isr J Med Sci; 1989 Jan; 25(1):20-4. PubMed ID: 2925353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of cocaine abuse and toxicity: an overview.
    Dunwiddie TV
    NIDA Res Monogr; 1988; 88():337-53. PubMed ID: 3145456
    [No Abstract]   [Full Text] [Related]  

  • 35. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mazindol on growth hormone levels in patients with Duchenne muscular dystrophy.
    Zatz M; Rapaport D; Vainzof M; Pavanello Rde C; Rocha JM; Betti RT; Otto PA
    Am J Med Genet; 1988 Dec; 31(4):821-33. PubMed ID: 3239574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
    Parker EM; Cubeddu LX
    J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
    Nikiforuk A; Gołembiowska K; Popik P
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.